reference/2424724

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2424724

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	483
issn	1557-7732 1080-7683
issueIdentifier	5
pageRange	475-483
publicationName	Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
startingPage	475
bibliographicCitation	Foster CS, DaVanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS. Durezol^® (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte^® 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis. Journal of Ocular Pharmacology and Therapeutics. 2010 Oct;26(5):475–83. doi: 10.1089/jop.2010.0059.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3613fc0486ddd8a23bc0edfcfca7d355 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c333815adb83640c7682a34d77ac428a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fcb32a8a231f33ae121f09efff85528 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e41b009c47aeb1458768b2d2e5443555 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cceef3275debd7ffbca4525fcd12c779 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dea6319338f42414eb1655cd0ecd430f
date	201010
identifier	https://doi.org/10.1089/jop.2010.0059 https://pubmed.ncbi.nlm.nih.gov/20809807
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20260 https://portal.issn.org/resource/ISSN/1557-7732 https://portal.issn.org/resource/ISSN/1080-7683
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Durezol® (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte® 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis
discusses	http://id.nlm.nih.gov/mesh/M0020910 http://id.nlm.nih.gov/mesh/M0001333 http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0055043 http://id.nlm.nih.gov/mesh/M0065341 http://id.nlm.nih.gov/mesh/M0008643 http://id.nlm.nih.gov/mesh/M0009322 http://id.nlm.nih.gov/mesh/M0007329
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014606Q000188 http://id.nlm.nih.gov/mesh/D005477Q000031 http://id.nlm.nih.gov/mesh/D000893Q000494 http://id.nlm.nih.gov/mesh/D011239Q000031 http://id.nlm.nih.gov/mesh/D005938Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007429 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005477Q000627 http://id.nlm.nih.gov/mesh/D005477Q000008 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000893Q000008 http://id.nlm.nih.gov/mesh/D013535Q000627 http://id.nlm.nih.gov/mesh/D011239Q000494 http://id.nlm.nih.gov/mesh/D011239Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000867Q000187 http://id.nlm.nih.gov/mesh/D014792Q000187 http://id.nlm.nih.gov/mesh/D004655Q000627 http://id.nlm.nih.gov/mesh/D005938Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9574 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443936 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c9a6abbfbceb6093666385f4bb3af227 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441236 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5834 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3100 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134411226 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135919923 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134359165 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129653353

Total number of triples: 71.